Items tagged with Treatment
India should heed a teenager’s historic fight for lifesaving TB treatment (post)
Malala Yousafzai and Greta Thunberg have shown us the formidable power of a single adolescent girl with determination. Shreya Tripathi of India, who didn’t live to see her 20th birthday, belongs with Malala and Greta in the pantheon of teenagers whose unswerving principles have brought the powerful to their knees.
Belarus to switch to WHO’s new treatment guidelines for MDR-TB (post)
“The World Health Organization has recently updated its treatment guidelines for multidrug-resistant tuberculosis (MDR-TB). Now all MDR-TB patients (not only those with extensively drug-resistant tuberculosis, XDR-TB) should get new medicines in line with the WHO's new recommendations,” Vyacheslav Grankov, Communicable Diseases Programme Coordinator of the World Health Organization in Belarus, said.
India: Despite free care, TB takes a toll of patients’ finances (post)
One in four patients affected by Tuberculosis (TB) has to spend out of his/her own pocket to access treatment, which should otherwise be anyway available for free.
Moxifloxacin not superior to ethambutol for recurrent TB (post)
Despite reducing the median time to culture conversion, replacing ethambutol with moxifloxacin has not shown efficacy in recurrent tuberculosis treatment success in an 8-week trial, according to a study published in Clinical Infectious Diseases. Moxifloxacin use was also linked with more adverse events.
Efavirenz and rifampicin together reduce levels of injectable contraception (post)
Women with HIV receiving depot medroxyprogesterone acetate (DMPA), with efavirenz (EFV)-based ART and rifampicin (RIF)-based TB treatment, had lower MPA plasma levels compared with women not receiving the two drugs.
Unitaid and Japan move to align their efforts against TB (post)
Tokyo, 2 April 2019 — Unitaid Executive Director Lelio Marmora and Parliamentary Vice-Minister for Foreign Affairs of Japan Kenji Yamada met today to discuss a new alignment between Japan’s global health priorities and Unitaid’s work in fighting tuberculosis.
TB killed Shreya Tripathi, but her death could have been avoided (post)
India's health ministry wanted to distribute a life saving TB drug only to patients in big cities. A girl from Patna fought the government and won, but it was too late for her.
Shorter treatments transform lives of TB patients in Kyrgyzstan (post)
Kyrgyzstan is one of 30 countries in the world with high rates of drug-resistant TB – 26 per cent of new cases of TB are drug resistant, compared to a world average of four per cent. And a staggering 61 per cent of reinfections are the drug resistant form, compared to 19 per cent globally.
Levofloxacin pharmacokinetics in children with drug-resistant TB exposure (post)
According to data published in Antimicrobial Agents and Chemotherapy, the dosing recommendations regarding levofloxacin for the treatment and prevention of drug-resistant tuberculosis (DR-TB) in children may need to be re-evaluated.
TB Alliance and Mylan announce global collaboration to commercialize investigational drug pretomanid as part of two regimens to treat TB (post)
NEW YORK, HERTFORDSHIRE, England and PITTSBURGH – April 18, 2019 – Non-profit drug developer, TB Alliance, and pharmaceutical company, Mylan N.V. (NASDAQ: MYL), today announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational drug regimens for pulmonary tuberculosis (TB).
Page 47 of 105 · Total posts: 0
←First 46 47 48 Last→